Cool excimer laser-assisted angioplasty (CELA) and tibial balloon angioplasty (TBA) in management of infragenicular arterial occlusion in critical lower limb ischemia (CLI)

Vascular and Endovascular Surgery

Volumn 47, Issue 3, 2013, Pages 179-191

  Sultan, Sherif ^a,b   Tawfick, Wael ^a   Hynes, Niamh ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b Galway Clinic   (Ireland)

Author keywords

angioplasty; critical limb ischemia; lasers; quality of life

Indexed keywords

HEMOGLOBIN A1C;

ANGIOPLASTY; ANKLE BRACHIAL INDEX; APUTATION FREE SURVIVAL; ARTICLE; COOL EXCIMER LASER ASSISTED ANGIOPLASTY; COST EFFECTIVENESS ANALYSIS; CRITICAL LOWER LIMB ISCHEMIA; DIABETES MELLITUS; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; LASER ANGIOPLASTY; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OVERALL SURVIVAL; QUALITY ADJUSTED LIFE YEAR; REVASCULARIZATION; SURVIVAL; SURVIVAL RATE; TIBIAL BALLOON ANGIOPLASTY;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; ANGIOPLASTY, BALLOON, LASER-ASSISTED; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; FEMALE; HEALTH CARE COSTS; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LASERS, EXCIMER; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; RISK FACTORS; TIBIAL ARTERIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875494808     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413478473     Document Type: Article

References (41)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45 (suppl S). S5 - S67
2. Nicoloff AD, Taylor LM, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg. 1998 ; 27 (2). 256-263
3. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008 ; 47 (5). 975-981
4. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter randomised controlled trial. Lancet. 2005 ; 366 (9501). 1925-1934
5. Clair DG, Dayal R, Faries PL, et al. Tibial angioplasty as an alternative strategy in patients with limb-threatening ischemia. Ann Vasc Surg. 2005 ; 19 (1). 63-68
6. Visonà A, Perissinotto C, Lusiani L, et al. Percutaneous excimer laser angioplasty of lower limb vessels: results of a prospective 24-month follow-up. Angiology. 1998 ; 49 (2). 91-98
7. Pokrovsky AV, Volynsky JuD, Konov VI, et al. Recanalisation of occluded peripheral arteries by excimer laser. Eur J Vasc Surg. 1990 ; 4 (6). 575-581
8. Biamino G.. The excimer laser: science fiction fantasy or practical tool?. J Endovasc Ther. 2004 ; 11 (suppl). II207 - II222
9. Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006 ; 13 (1). 1-11
10. Laird JR, Reiser C, Biamino G, Zeller T. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. J Cardiovasc Surg (Torino). 2004 ; 45 (3). 239-248
11. Bosiers M, Peeters P, Elst FV, et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg. 2005 ; 29 (6). 613-619
12. Tawfick W, Sultan S.. Tibial balloon angioplasty vs Excimer laser assisted angioplasty in management of infragenicular tibial arterial occlusion: an observational parallel group comparative study. J Cardiovasc Surg.. 2008 ; 49 (3). S22-23
13. Tan JW, Yeo KK, Laird JR. Excimer laser assisted angioplasty for complex infrainguinal peripheral artery disease: a 2008 update. J Cardiovasc Surg (Torino). 2008 ; 49 (3). 329-340
14. Second European Consensus Document on chronic critical leg ischemia. Circulation. 1991 ; 84 (suppl 4). IV1 - IV26
15. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006 ; 113 (11). e463 - e654
16. Heneghan HM, Sultan S.. Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia. J Endovasc Ther. 2008 ; 15 (4). 399-407
17. O'Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?. Eur J Vasc Endovasc Surg. 2006 ; 32 (2). 188-197
18. Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA. 2007 ; 297 (2). 169-176
19. Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. J Vasc Surg. 2009 ; 49 (2). 435-441
20. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation. 2007 ; 116 (17). e418 - e500
21. Oaikhinan K, Hirpara K, Akhtar Y, et al. An observational parallel group comparative study with and without the "Magic Bullet" in the perioperative and postoperative period for abdominal aortic aneurysms surgery and femoral-popliteal segment revascularisation. Br J Surg. 2004 ; 91 (1). 113-114
22. Lowery AJ, Hynes N, Manning BJ, Mahendran M, Tawfik S, Sultan S.. A prospective feasibility study of duplex ultrasound arterial mapping, digital-subtraction angiography, and magnetic resonance angiography in management of critical lower limb ischemia by endovascular revascularization. Ann Vasc Surg. 2007 ; 21 (4). 443-51
23. Sultan S, Esan O, Fahy A. Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular. 2008 ; 16 (3). 130-139
24. Noble S, Bilodeau L. High energy excimer laser to treat coronary in-stent restenosis in an underexpanded stent. Catheter Cardiovasc Interv. 2008 ; 71 (6). 803-807
25. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 ; 26 (3). 517-538
26. Diehm N, Pattynama PM, Jaff MR, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008 ; 36 (4). 409-419
27. Sacks D, Marinelli DL, Martin LG, Spies JB. Reporting standards for clinical evaluation of new peripheral arterial revascularisation devices. JVIR. 2003 ; 14: S395 - S404
28. Gelber RD, Gelman RS, Goldhirsh A. A quality-of-life-orientated endpoint for comparing therapies. Biometrics. 1989 ; 45 (3). 781-795
29. Brothers TE, Robison JG, Elliott BM. Prospective decision analysis for peripheral vascular disease predicts future quality of life. J Vasc Surg. 2007 ; 46 (4). 701-708
30. Vraux H, Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity?. Eur J Vasc Endovasc Surg. 2006 ; 32 (6). 663-667
31. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006 ; 43 (3). 498-503
32. Gray BH, Laird JR, Ansel GM, Shuck JW. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther. 2002 ; 9 (5). 599-604
33. Steinkamp H, Werk M, Haufe M, Felix R. Laser angioplasty of peripheral arteries after unsuccessful recanalization of the superficial femoral artery. Int J Cardiovasc Intervent. 2000 ; 3 (3). 153-160
34. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009 ; 16 (3). 251-260
35. Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular. 2009 ; 17 (1). 1-8
36. Deloose K, Bosiers M, Peeters P. One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia. EuroIntervention. 2009 ; 5 (3). 318-324
37. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol. 2004 ; 44 (12). 2307-2314
38. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009 ; 20 (9). 1141-1150
39. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg. 2008 ; 47 (1). 101-108
40. Aulivola B, Gargiulo M, Bessoni M, Rumolo A, Stella A.. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: do results justify its use?. Ann Vasc Surg.. 2005 ; 19 (6). 762-768
41. Kumada Y, Aoyama T, Ishii H, et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant. 2008 ; 23 (12). 3996-4001